AKASA launches autonomous AI platform for inpatient coding and CDI

On October 2, 2026, AKASA announced the launch of an autonomous AI platform for the mid-cycle of the healthcare revenue cycle. The South San Francisco-based company said the new platform expands its capabilities beyond AI-powered prebill review and into autonomous inpatient medical coding and clinical documentation integrity (CDI). AKASA describes itself as a leader in generative AI for the healthcare revenue cycle. The company also said its customers collectively represent more than $180 billion in net patient revenue. The announcement was reported by Unite.AI on the same day. The report’s headline summarized the offering as an autonomous AI platform for inpatient coding and clinical documentation.

The platform is positioned for the mid-cycle of the healthcare revenue cycle, while the prior area named in the announcement is AI-powered prebill review. The expansion moves into autonomous inpatient medical coding and CDI. Those are the specific capabilities named in the report.

AKASA is based in South San Francisco. In the announcement, it described itself as a leader in generative AI for the healthcare revenue cycle and cited its customers’ combined net patient revenue of more than $180 billion. The report does not include names of individual customers, pricing details, availability dates, or platform performance metrics. It also does not describe any next steps after the launch announcement. No other details about deployment, integration, or clinical outcomes are provided in the supplied report. The report is dated October 2, 2026, at 19:29. As covered, the event remains at the point of AKASA’s October 2, 2026 announcement.